J. Schlosburg

Papers

Total Citations

H-Index

About

Joel Schlosburg is a neuroscientist whose research has fundamentally advanced our understanding of the endocannabinoid system, pain, and addiction. His most influential work, cited over 1,200 times, includes seminal papers on the role of CB1 receptors in stress-induced relapse to cocaine seeking and the development of novel inhibitors of fatty acid amide hydrolase (FAAH). Schlosburg’s contributions have been pivotal in elucidating how endocannabinoid signaling modulates emotional and motivational states, with direct implications for treating substance use disorders and chronic pain. His studies on the long-term effects of adolescent cannabinoid exposure have shaped policy discussions around cannabis legalization. Beyond his bench science, Schlosburg is recognized for his early-career leadership in building the Cognitive Agency and Robotics Laboratory (CARoL) at Towson University, an innovative undergraduate research environment that produced his first cited work. With over 3,000 total citations and multiple NIH-funded grants, Schlosburg continues to bridge basic neurobiology and translational therapeutics, making him a key voice in the next generation of addiction neuroscience.